MWG Caph’s Beam Therapeutics BEAM Stock Holding History
Bought
Maintained
Sold
Other funds holding BEAM
MWG Caph's BEAM Position: Q4 2025 in Review
MWG Caph opened a new position in Beam Therapeutics (BEAM) in Q4 2025: 1,266,934 shares worth $35.1M. The stake represents 48.53% of the portfolio and ranks #1 among its holdings.
248 funds tracked by Wall St. Rank hold BEAM as of Q4 2025.
- MWG Caph held 1,266,934 shares of Beam Therapeutics worth $35.1M as of Q4 2025.
- Beam Therapeutics was a new MWG Caph position in Q4 2025.
- Beam Therapeutics made up 48.53% of MWG Caph's portfolio in Q4 2025, its #1 holding.
- 248 funds tracked by Wall St. Rank held Beam Therapeutics as of Q4 2025.
Based on MWG Caph's 13F filing for Q4 2025, filed 17 Feb 2026.